TL;DR: The Centers for Medicare & Medicaid Services modified NCD 92, the National Coverage Determination governing the closed-loop blood glucose control device (CBGCD), effective March 7, 2026. Here's what changes for billing teams.
This policy modification clarifies the CMS closed-loop blood glucose control device coverage policy under NCD 92 in the Medicare system. The policy does not list specific CPT or HCPCS codes. If your facility bills for CBGCD services in an inpatient hospital setting, this update affects how you document and justify medical necessity for Type I diabetic patients in crisis situations.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Closed-Loop Blood Glucose Control Device (CBGCD) |
| Policy Code | NCD 92 |
| Change Type | Modified |
| Effective Date | 2026-03-07 |
| Impact Level | Medium |
| Specialties Affected | Hospital inpatient billing, endocrinology, surgery, obstetrics, trauma/critical care |
| Key Action | Audit inpatient CBGCD claims for documentation of crisis indications, trained personnel, and inpatient setting before billing |
CMS Closed-Loop Blood Glucose Control Device Coverage Criteria and Medical Necessity Requirements 2026
NCD 92 is the National Coverage Determination governing Medicare coverage of the closed-loop blood glucose control device. The CBGCD is a hospital bedside system — not durable medical equipment — designed for short-term glucose management in patients with insulin-dependent diabetes mellitus (Type I).
The device is not a simple monitor. It combines a rapid on-line glucose analyzer, a computer controller that calculates and manages infusion of either insulin or dextrose, a multi-channel infusion system, and a printer that records continuous glucose values and cumulative infusion totals. The system acts on blood glucose in real time, correcting both hyperglycemia and hypoglycemia through automated infusion.
What Medical Necessity Looks Like Under This Coverage Policy
CMS covers the CBGCD under three hard requirements. All three must be met:
| # | Covered Indication |
|---|---|
| 1 | The patient is an insulin-dependent (Type I) diabetic in a crisis situation. The policy specifically names trauma, labor and delivery, and surgery as covered crisis contexts. These are situations with wide, unpredictable fluctuations in blood sugar levels. |
| 2 | The setting is inpatient hospital only. This is not an outpatient benefit. There is no mechanism under NCD 92 for CBGCD reimbursement outside an inpatient admission. |
| 3 | Use is under the direction of specially trained medical personnel. The policy requires continuous observation by trained staff. This is not a device your nursing staff can deploy without documented specialized training. |
Miss any one of these three criteria on your documentation, and you're looking at a claim denial.
Duration Limits and Why They Matter for Billing
CMS limits CBGCD use to 24 to 48 hours. The policy is explicit about this. The reason: potential complications including sepsis, thromboses, and the device's nonportability.
This duration ceiling is a billing signal. If your documentation shows CBGCD use extending beyond 48 hours without strong clinical justification, expect scrutiny. Build your charge capture and clinical documentation workflow around this window.
Prior Authorization Under NCD 92
The policy does not specify a prior authorization requirement for the CBGCD. However, the narrow coverage criteria — crisis situation, inpatient only, specially trained personnel — function as a de facto prior auth checklist. Your documentation must answer all three before a claim goes out the door.
If your Medicare Administrative Contractor has issued a local coverage determination or billing article that layers additional requirements on top of NCD 92, those MAC-level rules apply too. Check with your MAC before the effective date of March 7, 2026 if you're unsure.
CMS Closed-Loop Blood Glucose Control Device Exclusions and Non-Covered Indications
NCD 92 is narrow by design. The exclusions are implied rather than explicitly listed, but they're clear from the coverage criteria.
Type II diabetes is not covered. The policy covers insulin-dependent diabetics, which under the NCD means Type I. If your facility uses the CBGCD for a Type II patient — even in a surgical or trauma setting — that's outside the policy's scope.
Outpatient and non-inpatient settings are not covered. The benefit category is inpatient hospital services, full stop. No observation status, no outpatient department, no ambulatory surgical center.
Routine or elective glucose management is not covered. The policy language is "crisis situations" and "periods of stress." Stable patients don't meet medical necessity under this NCD, even if a physician believes the CBGCD would be beneficial.
Use beyond 48 hours without documented medical necessity is not covered. The policy ties the 48-hour limit to complication risk. Document your clinical rationale if you extend use — and expect that extended-use claims will face review.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Type I diabetic in crisis — surgical setting | Covered | No specific codes listed in NCD 92 | Inpatient only; must be under direction of specially trained personnel |
| Type I diabetic in crisis — trauma setting | Covered | No specific codes listed in NCD 92 | Inpatient only; duration limited to 24–48 hours |
| Type I diabetic — labor and delivery | Covered | No specific codes listed in NCD 92 | Inpatient only; crisis or stress-period presentation required |
| Type II diabetic — any setting | Not Covered | N/A | Policy covers insulin-dependent (Type I) only |
| Outpatient or observation-status patients | Not Covered | N/A | Inpatient hospital benefit category only |
| Routine or elective glucose stabilization | Not Covered | N/A | "Crisis situation" is a hard medical necessity requirement |
| CBGCD use beyond 48 hours | Not Covered (absent strong documentation) | N/A | CMS cites sepsis, thrombosis risk; document extended use carefully |
CMS Closed-Loop Blood Glucose Control Device Billing Guidelines and Action Items 2026
The real issue with CBGCD billing is documentation. The device is specialized, the coverage window is narrow, and every element of the NCD 92 criteria needs to show up in the medical record before your billing team touches the claim.
Here's what to do before and after March 7, 2026:
| # | Action Item |
|---|---|
| 1 | Confirm your facility's current CBGCD billing process before March 7, 2026. Pull the last six months of inpatient claims that include CBGCD charges. Verify that each claim documents a Type I diabetic patient, a qualifying crisis situation (trauma, surgery, or labor and delivery), and inpatient status. |
| 2 | Update your clinical documentation templates to capture all three coverage criteria. Your physicians and nursing staff need a structured documentation workflow that records patient diagnosis (Type I diabetes), the specific crisis context, and confirmation that specially trained personnel directed and observed the device use. A checklist in the EHR order set works well for this. |
| 3 | Flag any CBGCD charges with duration exceeding 48 hours for clinical review before billing. Build a hard stop or soft alert in your charge capture system. Claims with extended use need an attending note explaining why the clinical situation required it. Without that note, you're exposed on audit. |
| 4 | Verify that no local coverage determination from your MAC adds requirements on top of NCD 92. NCD 92 sets the floor. Your MAC can layer additional billing guidelines, documentation requirements, or covered diagnosis criteria. Contact your MAC or check their website for any CBGCD-specific billing articles before the effective date. |
| 5 | Confirm that personnel training records are accessible for audit. The NCD requires "specially trained medical personnel." If CMS or a Recovery Audit Contractor asks for proof, your compliance officer needs to produce training documentation fast. Make sure those records exist and are linked to the relevant patient encounters. |
| 6 | Do not bill CBGCD services for Type II diabetic patients regardless of clinical complexity. This is a hard line in the policy. If your medical director believes a Type II patient in crisis would benefit from the CBGCD, that's a clinical conversation — but it's not a covered claim under NCD 92. Talk to your compliance officer before billing in any gray-area diabetes classification situation. |
| 7 | Verify benefit category coding reflects inpatient hospital services. Since the benefit category is inpatient hospital — not DME, not outpatient — make sure your claim form and revenue codes align. A CBGCD claim hitting under the wrong benefit category will deny on technical grounds before anyone even looks at medical necessity. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Closed-Loop Blood Glucose Control Device Under NCD 92
Covered CPT and HCPCS Codes
The policy data for NCD 92 does not list specific CPT or HCPCS codes. CMS has not assigned dedicated procedure codes to the CBGCD in this NCD. Closed-loop blood glucose control device billing likely flows through your facility's charge description master under inpatient hospital revenue codes.
Contact your MAC or billing consultant to confirm the correct revenue code and any applicable HCPCS codes your facility should use to capture CBGCD charges on an inpatient claim. Do not assume a code is correct because it's on your CDM — verify it against current MAC guidance.
Key ICD-10-CM Diagnosis Codes to Consider
NCD 92 does not list specific ICD-10-CM codes. Based on the policy criteria — insulin-dependent (Type I) diabetes in crisis — your coding team should evaluate the following diagnosis categories when supporting CBGCD claims:
- Type I diabetes with hypoglycemia (crisis presentation)
- Type I diabetes with hyperglycemia (crisis presentation)
- Type I diabetes as a complicating condition in trauma, surgical, or obstetric encounters
Work with your clinical documentation specialists to confirm the right ICD-10-CM codes for your patient mix. Do not guess — the diagnosis code you put on the claim needs to match the patient's documented condition and align with the NCD's medical necessity criteria. If you're uncertain about diagnosis code selection, loop in your compliance officer before the claim goes out.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.